Iris Roth's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 297,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals Inc | Iris Roth | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 297,500 | 297,500 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Iris Roth | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 52,500 | 52,500 | - | 0 | Common Stock |